NCT00004815View on ClinicalTrials.gov

Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome

NACompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 31, 1992

Conditions
Werner's Syndrome
Interventions
DRUG

growth hormone

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

University of Texas

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004815 - Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome | Biotech Hunter | Biotech Hunter